The Detrimental Effect of Pre-Treatment with Ivermectin on Myocardial Ischemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Detrimental Effect of Pre-Treatment with Ivermectin on Myocardial Ischemia
Authors
Keywords
-
Journal
PHARMACOLOGY
Volume -, Issue -, Pages 1-9
Publisher
S. Karger AG
Online
2023-10-26
DOI
10.1159/000534206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Injectable Dual‐Function Hydrogel Protects Against Myocardial Ischemia/Reperfusion Injury by Modulating ROS/NO Disequilibrium
- (2022) Tian Hao et al. Advanced Science
- Ivermectin for Prevention and Treatment of COVID-19 Infection
- (2021) Andrew Bryant et al. AMERICAN JOURNAL OF THERAPEUTICS
- Epidemiology of cardiovascular disease in Europe
- (2021) Nick Townsend et al. Nature Reviews Cardiology
- Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
- (2021) Shican Zhou et al. Frontiers in Pharmacology
- Anti-inflammatory Effects of Ivermectin in the Treatment of Acetic Acid-Induced Colitis in Rats: Involvement of GABAB Receptors
- (2021) Armin Aryannejad et al. DIGESTIVE DISEASES AND SCIENCES
- Anabolic steroid excess and myocardial infarction: from ischemia to reperfusion injury
- (2020) Fernando A.C. Seara et al. STEROIDS
- Mechanisms of ivermectin-induced wound healing
- (2020) Daniel Kwesi Sia et al. BMC Veterinary Research
- Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies
- (2020) Kosar Jannesar et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oxidative Stress, Kinase Activity and Inflammatory Implications in Right Ventricular Hypertrophy and Heart Failure under Hypobaric Hypoxia
- (2020) Eduardo Pena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy
- (2019) Simona Gallo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
- (2019) Lu Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Methamphetamine Use and Cardiovascular Disease
- (2019) Christopher G. Kevil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Arrhythmia-induced cardiomyopathy
- (2018) Samuel Sossalla et al. Deutsches Arzteblatt International
- Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea
- (2017) M. Schaller et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- European guideline for the management of scabies
- (2017) C.M. Salavastru et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice
- (2017) Jianshu Gao et al. Molecular Medicine Reports
- Ivermectin – Old Drug, New Tricks?
- (2017) Roz Laing et al. TRENDS IN PARASITOLOGY
- Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine
- (2015) Wesley C. Van Voorhis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
- (2014) A. Melotti et al. EMBO Molecular Medicine
- Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats
- (2014) Hamid Soraya et al. Pharmacological Reports
- The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
- (2013) Lihua Jin et al. Nature Communications
- Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
- (2012) Jun Pu et al. EUROPEAN HEART JOURNAL
- Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
- (2012) E. Mastrangelo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin
- (2012) Timothy Lynagh et al. Frontiers in Molecular Neuroscience
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cells
- (2011) Y. Yu et al. CARCINOGENESIS
- Retrograde heart perfusion: The Langendorff technique of isolated heart perfusion
- (2011) Robert M. Bell et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A Role of the Bile Salt Receptor FXR in Atherosclerosis
- (2010) Jurre Hageman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells
- (2010) S. Sharmeen et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started